Projects per year
Personal profile
Personal profile
Dr. Bing Liao is Board Certified for Neurology, Neuromuscular Medicine and Electrodiagnostic Medicine. She is specialized in wide range of neuromuscular disorders: neuropathy, amyotrophyic lateral sclerosis (ALS), myasthenia gravis, inflammatory myopathy and muscular dystrophy. She is also specialized in various headache syndromes. She performs electrodiagnostic testing, botulinum toxin injections and occipital nerve blocks.
Research interests
Dr. Liao's research interests include laboratory and clinical studies of new therapies for myasthenia gravis, congenital myasthenic syndrome, muscular dystrophy, ALS, CIDP and cancer related neuromuscular disorders. Dr. Liao has been the recipient of several awards and honors through the course of her professional career, including “The American Police Hall of Fame, Life Saving Award”.
Dr. Liao has authored and co-authored many published manuscripts in peer-reviewed clinical and scientific journals, and presented at numerous national and international scientific and clinical annual meetings and conferences.
Research Area Keywords
- Neurosciences
Fingerprint
Dive into the research topics where Bing Liao is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
HEALEY ALS Platform Trial - Regimen-Specific Appendix B - For verdiperstat (also known as BHV-3241)
Appel, S. H., Shroff, S., Greene, E. P., Liao, B. & Thonhoff, J. R.
7/24/20 → 7/23/25
Project: Non Profit
-
HEALEY ALS Platform Trial - Regimen-Specific Appendix A - For 0.3mh/kg SC zilucoplan administered once daily and placebo
Appel, S. H., Shroff, S., Greene, E. P., Liao, B. & Thonhoff, J. R.
7/24/20 → 7/23/25
Project: Non Profit
-
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development
for the Healey ALS Platform Trial Study Group, HEALEY ALS Platform Trial Study Group, Biostatisticians, Investigators, Clinical Operations Team & Medical Monitors, Feb 1 2022, In: Annals of Neurology. 91, 2, p. 165-175 11 p.Research output: Contribution to journal › Article › peer-review
Open Access34 Scopus citations -
Brachial Plexopathies: Update on Treatment
Shanina, E., Liao, B. & Smith, R. G., May 1 2019, In: Current Treatment Options in Neurology. 21, 5, 24.Research output: Contribution to journal › Review article › peer-review
9 Scopus citations -
Neurological complications associated with anti–programmed death 1 (PD-1) antibodies
Kao, J. C., Liao, B., Markovic, S. N., Klein, C. J., Naddaf, E., Staff, N. P., Liewluck, T., Hammack, J. E., Sandroni, P., Finnes, H. & Mauermann, M. L., Oct 2017, In: JAMA Neurology. 74, 10, p. 1216-1222 7 p.Research output: Contribution to journal › Article › peer-review
225 Scopus citations -
Alternating ptosis associated with asialo-GM1 and GD1b antibodies
Liao, B., Kamiya-Matsuoka, C., Fang, X., Smith, R. G. & Shanina, E., Dec 1 2016, In: International Journal of Neuroscience. 126, 12, p. 1139-1141 3 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Atypical isolated nuclear oculomotor nerve syndrome: A diagnostic challenge
Liao, B. & Kamiya-Matsuoka, C., Feb 18 2015, In: BMJ Case Reports. 2015Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations